mTORC1 in energy expenditure: consequences for obesity

Nat Rev Endocrinol. 2024 Apr;20(4):239-251. doi: 10.1038/s41574-023-00934-0. Epub 2024 Jan 15.

Abstract

In eukaryotic cells, the mammalian target of rapamycin complex 1 (sometimes referred to as the mechanistic target of rapamycin complex 1; mTORC1) orchestrates cellular metabolism in response to environmental energy availability. As a result, at the organismal level, mTORC1 signalling regulates the intake, storage and use of energy by acting as a hub for the actions of nutrients and hormones, such as leptin and insulin, in different cell types. It is therefore unsurprising that deregulated mTORC1 signalling is associated with obesity. Strategies that increase energy expenditure offer therapeutic promise for the treatment of obesity. Here we review current evidence illustrating the critical role of mTORC1 signalling in the regulation of energy expenditure and adaptive thermogenesis through its various effects in neuronal circuits, adipose tissue and skeletal muscle. Understanding how mTORC1 signalling in one organ and cell type affects responses in other organs and cell types could be key to developing better, safer treatments targeting this pathway in obesity.

Publication types

  • Review

MeSH terms

  • Energy Metabolism / physiology
  • Humans
  • Insulin / metabolism
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Obesity* / metabolism
  • Signal Transduction* / physiology

Substances

  • Mechanistic Target of Rapamycin Complex 1
  • Insulin